Clinical Trial Update: Treatment of Angioedema Attacks in Pediatric (Ages 2-11) Post-Trial and Naive Patients With HAE With Sebetralstat

View source ↗

Summary

This clinical trial update reports on the use of Sebetralstat for treating angioedema attacks in pediatric patients aged 2-11 with hereditary angioedema, includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Sebetralstat (Sebetralstat)

Snippet

Sponsor: KalVista Pharmaceuticals, Ltd. | Conditions: Hereditary Angioedema | Status: AVAILABLE